Screening for diabetes: can we afford not to screen?
Nathan
David M
DM
Herman
William H
WH
D003362:Cost-Benefit Analysis; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000175:diagnosis*; D003925:Diabetic Angiopathies / Q000150:complications; D006801:Humans; D006973:Hypertension / Q000150:complications; D008403:Mass Screening / Q000191:economics*